Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FQGhk6JtPdd2OdsqPPrWY5OAb1kE.uncropped.jpg&w=3840&q=75)
Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check31 days agoNo Change Detected
- Check46 days agoChange DetectedThe study has been updated to version v2.10.0, with two locations now included, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check67 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check72 days agoChange DetectedThe value of Revision has changed from v2.9.3 to v2.9.5, indicating an update or modification to the content of the web page.SummaryDifference0.1%
Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.